Advent International, a privately owned firm headquartered in the US, was founded in 1984 and employs approximately 970 individuals. It operates as venture capital and private equity principals, investing in sectors including technology, media and telecoms, financial services, and healthcare.
On April 28, 2026, KONE and a consortium led by Advent International and Cinven entered into an agreement to combine KONE and TKE in a cash and share transaction, valuing TKE at EUR 29.4 billion. This transaction aims to create a global company in the elevator and escalator industry, bringing together two businesses with complementary geographic footprints and innovation platforms, following TKE's establishment as an independent entity after its carve-out from thyssenkrupp AG. Previously, on April 27, Advent-backed Cohance Lifesciences appointed Umang Vohra as its chairman and group chief executive officer, replacing Sharma, to revive growth for the contract development and manufacturing platform amidst regulatory and operational challenges. Also on April 26, the European Commission approved the acquisition of joint control of Volue AS by Arendals Fossekompani ASA (AFK), Advent International L.P., and TA Associates Management L.P. Earlier, on April 23, Caldic, a global chemicals distributor majority-owned by Advent International, faced an investigation in Brazil for allegedly supplying a methanol smuggling racket.
Subscribe for full access to Advent International's products in full detail
Subscribe for full access to Advent International's revenue in full detail
Subscribe for full access to Advent International's products in full detail 
